The Verge · Richard Lawler ·

Midjourney unveils its first hardware product, the Midjourney Scanner, an ultrasound-based full-body scanner; it is unclear how AI fits into the medical effort

The AI image generator says this side project will be 'in many ways superior to even MRI machines.'

Midjourney unveils its first hardware product, the Midjourney Scanner, an ultrasound-based full-body scanner; it is unclear how AI fits into the medical effort

Lead Source

How this story grew

Coverage · 0 Discussion · 0
Jun 18Jun 19

More

Midjourney: Midjourney
The Register: The Register
Bloomberg: Bloomberg
Business Wire: Business Wire
PYMNTS: PYMNTS
Engadget: Engadget
Decrypt: Decrypt
Latent.Space: Latent.Space
Business Insider: Business Insider
Core Memory: Core Memory
TBPN: TBPN
Gizmodo: Gizmodo
Inc: Inc
Business Today: Business Today
iPhone in Canada: iPhone in Canada
PetaPixel: PetaPixel
Tech Times: Tech Times
The Decoder: The Decoder
Mashable: Mashable
The Next Web: The Next Web
The Neuron: The Neuron
Benzinga: Benzinga
The Information: The Information
RuntimeWire: RuntimeWire

Discussion

TechSnif Coverage

Midjourney Jumps Into Hardware With Full-Body Scanner

The AI image generator unveils an ultrasound-based body scanner as its first physical product.

Midjourney just made the weirdest pivot in recent tech memory. The company best known for generating AI art has unveiled its first hardware product — and it's a medical device.

The Midjourney Scanner is an ultrasound-based full-body scanner. The company claims the device will be "in many ways superior to even MRI machines." That's a bold statement from a startup with zero track record in medical imaging hardware.

Perhaps the strangest part: it's unclear how AI actually fits into this effort. Midjourney built its reputation on generative AI image models, but the connection between dreamy AI art and diagnostic body scanning remains unexplained.

The scanner is being described as a side project, which is an interesting way to characterize a medical device that presumably requires FDA scrutiny. No pricing, availability, or clinical validation details have been shared yet.